JP2024535845A5 - - Google Patents

Info

Publication number
JP2024535845A5
JP2024535845A5 JP2024516797A JP2024516797A JP2024535845A5 JP 2024535845 A5 JP2024535845 A5 JP 2024535845A5 JP 2024516797 A JP2024516797 A JP 2024516797A JP 2024516797 A JP2024516797 A JP 2024516797A JP 2024535845 A5 JP2024535845 A5 JP 2024535845A5
Authority
JP
Japan
Prior art keywords
arg
pharmaceutical preparation
approximately
peptide
trp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024516797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535845A (ja
Filing date
Publication date
Priority claimed from US17/730,042 external-priority patent/US20230106943A1/en
Application filed filed Critical
Publication of JP2024535845A publication Critical patent/JP2024535845A/ja
Publication of JP2024535845A5 publication Critical patent/JP2024535845A5/ja
Pending legal-status Critical Current

Links

JP2024516797A 2021-09-17 2022-09-14 操作された抗微生物ペプチドおよびその使用方法 Pending JP2024535845A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163245770P 2021-09-17 2021-09-17
US63/245,770 2021-09-17
US17/730,042 2022-04-26
US17/730,042 US20230106943A1 (en) 2021-09-17 2022-04-26 Engineered antimicrobial peptides and usage thereof
PCT/US2022/076421 WO2023044339A1 (en) 2021-09-17 2022-09-14 Engineered antimicrobial peptides and usage thereof

Publications (2)

Publication Number Publication Date
JP2024535845A JP2024535845A (ja) 2024-10-02
JP2024535845A5 true JP2024535845A5 (enExample) 2026-01-21

Family

ID=85603598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024516797A Pending JP2024535845A (ja) 2021-09-17 2022-09-14 操作された抗微生物ペプチドおよびその使用方法

Country Status (6)

Country Link
US (2) US20230106943A1 (enExample)
EP (1) EP4401754A4 (enExample)
JP (1) JP2024535845A (enExample)
AU (1) AU2022345264A1 (enExample)
CA (1) CA3231957A1 (enExample)
WO (1) WO2023044339A1 (enExample)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036627A1 (en) * 2001-02-16 2003-02-20 Montelaro Ronald C. Virus derived antimicrobial peptides
PE20110543A1 (es) * 2008-08-15 2011-08-04 Ironwood Pharmaceuticals Inc Formulacion solida oral que comprende linaclotida, cation de calcio y leucina
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
US11236314B2 (en) * 2017-03-30 2022-02-01 Bactoclear Holdings Pte. Ltd Chimeric lysm polypeptides
WO2019089657A1 (en) * 2017-10-30 2019-05-09 Allvivo Vascular, Inc. Delivery systems for administration of cationic biological actives
EP3765057A4 (en) * 2018-03-13 2022-01-05 Peptilogics, Inc. TREATMENT OF IMPLANTS WITH GENERALLY MODIFIED AMPHIPHILIC PEPTIDES
JP2023501385A (ja) * 2019-11-08 2023-01-18 ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 抗微生物ペプチドを含む組成物
AU2022346034A1 (en) * 2021-09-17 2024-04-04 Peptilogics, Inc. Engineered antimicrobial peptides and usage thereof

Similar Documents

Publication Publication Date Title
AU2007238114B2 (en) Rapid acting and long acting insulin combination formulations
ES2253774T3 (es) Formulacion farmaceutica conteniendo hormona de crecimiento humana, histidina y un detergente no ionico.
JP2024099628A5 (enExample)
JP5424887B2 (ja) ペプチド及び関連化合物の経皮送達システム
ES2391776T3 (es) Formulaciones solubles, estables conteniendo insulina con una sal de protamina
CN101272764B (zh) hFSH水制剂
US6150331A (en) Human growth hormone-containing aqueous pharmaceutical composition
CN103596582B (zh) 药用组合物
GB2112641A (en) The use of peptides as medicaments
ES2275276T3 (es) Procedimiento de administracion de igf - i.
JP4053586B2 (ja) ガンマインターフェロンの安定液体組成物
US20250090622A1 (en) Angiotensin compositions and methods related thereto
JP2024536768A5 (enExample)
RU2013128357A (ru) Стабильный готовый к применению инъекционный раствор цетрореликса
US20050074485A1 (en) Anti-inflammatory/anti-microbial peptides for use in dialysis
KR100271671B1 (ko) 고농도 tcf 주사제
WO2017183559A1 (ja) 薬物の経粘膜吸収促進剤
JP2024535845A5 (enExample)
KR101838759B1 (ko) 점안제
JPH0338255B2 (enExample)
ES2358018T3 (es) Uso de compuestos de kahalalida para la fabricación de un medicamento para el tratamiento de la psoriasis.
JPH02145527A (ja) エイズ治療および阻害剤
JP3002725B2 (ja) 線維芽細胞増殖因子関連ペプチドからなる医薬組成物
CN102440957A (zh) 醋酸特利加压素鼻腔喷雾剂及其制备方法
JP5970439B2 (ja) ペプチド及び関連化合物の経皮送達システム